Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Whole Exome Sequencing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Whole Exome Sequencing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Segmented by End User/Segment
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Thermo Fisher
Sengenics
Roche
Novo Gene
Macrogen
Illumina
Eurofins
BGI
Angilent
Ambry
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Whole Exome Sequencing Market Status and Forecast (2016-2027) 1.3.2 Global Whole Exome Sequencing Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Whole Exome Sequencing Supply by Company 2.1 Global Whole Exome Sequencing Sales Volume by Company 2.2 Global Whole Exome Sequencing Sales Value by Company 2.3 Global Whole Exome Sequencing Price by Company 2.4 Whole Exome Sequencing Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Whole Exome Sequencing Market Status by Category 3.1 Whole Exome Sequencing Category Introduction 3.1.1 Agilent HaloPlex 3.1.2 Agilent SureSelect 3.1.3 Agilent SureSelect QXT 3.1.4 Illumina TruSeq Exome 3.1.5 Roche Nimblegen SeqCap 3.1.6 MYcroarray MYbaits 3.2 Global Whole Exome Sequencing Market by Category 3.2.1 Global Whole Exome Sequencing Sales Volume by Category (2016-2021) 3.2.2 Global Whole Exome Sequencing Sales Value by Category (2016-2021) 3.2.3 Global Whole Exome Sequencing Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Whole Exome Sequencing Market Status by End User/Segment 4.1 Whole Exome Sequencing Segment by End User/Segment 4.1.1 Correlation Research of Normal Human 4.1.2 Mendelian Disease and Rare Syndrome Gene Discovery 4.1.3 The Research of Complex Diseases 4.1.4 Mouse Exome Sequencing 4.2 Global Whole Exome Sequencing Market by End User/Segment 4.2.1 Global Whole Exome Sequencing Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Whole Exome Sequencing Sales Value by End User/Segment (2016-2021) 4.2.3 Global Whole Exome Sequencing Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Whole Exome Sequencing Market Status by Region 5.1 Global Whole Exome Sequencing Market by Region 5.1.1 Global Whole Exome Sequencing Sales Volume by Region 5.1.2 Global Whole Exome Sequencing Sales Value by Region 5.2 North America Whole Exome Sequencing Market Status 5.3 Europe Whole Exome Sequencing Market Status 5.4 Asia Pacific Whole Exome Sequencing Market Status 5.5 Central & South America Whole Exome Sequencing Market Status 5.6 Middle East & Africa Whole Exome Sequencing Market Status6 North America Whole Exome Sequencing Market Status 6.1 North America Whole Exome Sequencing Market by Country 6.1.1 North America Whole Exome Sequencing Sales Volume by Country (2016-2021) 6.1.2 North America Whole Exome Sequencing Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Whole Exome Sequencing Market Status 7.1 Europe Whole Exome Sequencing Market by Country 7.1.1 Europe Whole Exome Sequencing Sales Volume by Country (2016-2021) 7.1.2 Europe Whole Exome Sequencing Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Whole Exome Sequencing Market Status 8.1 Asia Pacific Whole Exome Sequencing Market by Country 8.1.1 Asia Pacific Whole Exome Sequencing Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Whole Exome Sequencing Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Whole Exome Sequencing Market Status 9.1 Central & South America Whole Exome Sequencing Market by Country 9.1.1 Central & South America Whole Exome Sequencing Sales Volume by Country (2016-2021) 9.1.2 Central & South America Whole Exome Sequencing Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Whole Exome Sequencing Market Status 10.1 Middle East & Africa Whole Exome Sequencing Market by Country 10.1.1 Middle East & Africa Whole Exome Sequencing Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Whole Exome Sequencing Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Whole Exome Sequencing Manufacturing Cost Analysis 11.5 Whole Exome Sequencing Sales Channel and Distributors Analysis 11.5.1 Whole Exome Sequencing Sales Channel 11.5.2 Whole Exome Sequencing Distributors 11.6 Whole Exome Sequencing Downstream Major Buyers12 Global Whole Exome Sequencing Market Forecast by Category and by End User/Segment 12.1 Global Whole Exome Sequencing Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Whole Exome Sequencing Forecast by Category 12.2.1 Global Whole Exome Sequencing Sales Volume Forecast by Category 12.2.2 Global Whole Exome Sequencing Sales Value Forecast by Category 12.2.3 Global Whole Exome Sequencing Price Forecast by Category 12.3 Global Whole Exome Sequencing Forecast by End User/Segment 12.3.1 Global Whole Exome Sequencing Sales Volume Forecast by End User/Segment 12.3.2 Global Whole Exome Sequencing Sales Value Forecast by End User/Segment 12.3.3 Global Whole Exome Sequencing Price Forecast by End User/Segment13 Global Whole Exome Sequencing Market Forecast by Region/Country 13.1 Global Whole Exome Sequencing Market Forecast by Region (2022-2027) 13.1.1 Global Whole Exome Sequencing Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Whole Exome Sequencing Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Thermo Fisher 14.1.1 Company Information 14.1.2 Whole Exome Sequencing Product Introduction 14.1.3 Thermo Fisher Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Sengenics 14.2.1 Company Information 14.2.2 Whole Exome Sequencing Product Introduction 14.2.3 Sengenics Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Roche 14.3.1 Company Information 14.3.2 Whole Exome Sequencing Product Introduction 14.3.3 Roche Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Novo Gene 14.4.1 Company Information 14.4.2 Whole Exome Sequencing Product Introduction 14.4.3 Novo Gene Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Macrogen 14.5.1 Company Information 14.5.2 Whole Exome Sequencing Product Introduction 14.5.3 Macrogen Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Illumina 14.6.1 Company Information 14.6.2 Whole Exome Sequencing Product Introduction 14.6.3 Illumina Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Eurofins 14.7.1 Company Information 14.7.2 Whole Exome Sequencing Product Introduction 14.7.3 Eurofins Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 BGI 14.8.1 Company Information 14.8.2 Whole Exome Sequencing Product Introduction 14.8.3 BGI Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Angilent 14.9.1 Company Information 14.9.2 Whole Exome Sequencing Product Introduction 14.9.3 Angilent Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Ambry 14.10.1 Company Information 14.10.2 Whole Exome Sequencing Product Introduction 14.10.3 Ambry Whole Exome Sequencing Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology